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Abstract: The feasibility of using a permeabilized prepara- 
tion of human SH-SY6Y neuroblastoma cells for studies 
of muscarinic acetylcholine receptor (mAChR) sequestra- 
tion has been evaluated. Exposure of cells permeabilized 
with digitonin, streptolysin-0, or the a-toxin from Staphylo- 
coccus aureus to oxotremorine-M (0x0-M) for 30 min re- 
sulted in a 25-30% reduction in the number of cell surface 
mAChRs, as monitored by the loss of N[3H]methyl- 
scopolamine (f'H]NMS) binding sites. The corresponding 
value for intact cells was 40%. For cells permeabilized 
with 20 pM digitonin, the 0x0-M-mediated reduction in 
[3H]NMS binding was time (f,,2 - 5 min) and concentration 
(EC, - 10 pM) dependent and was agonist specific (0x0- 
M > bethanechol = arecoline = pilocarpine). In contrast, 
no reduction in total mAChR number, as monitored by the 
binding of [3H]quinuclidinyl benzilate, occurred following 
0x0-M treatment. The loss of [3H]NMS sites observed in 
the presence of 0x0-M was unaffected by omission of 
either ATP or Ca*', both of which are required for stimu- 
lated phosphoinositide hydrolysis, but could be inhibited 
by the inclusion of guanosine 5'0(2-thiodiphosphate). 
mAChRs sequestered in response to 0x0-M addition 
were unmasked when the cells were permeabilized in the 
presence of higher concentrations of digitonin (80 pM).  
The results indicate (a) that permeabilized SH-SY6Y cells 
support an agonist-induced sequestration of mAChRs, 
the magnitude of which is -65-70% of that observed for 
intact cells, (b) that when internalized, mAChRs are lo- 
cated in a cellular compartment to which [3H]NMS has only 
a limited access despite the removal of the plasma mem- 
brane barrier, and (c) that the production of phosphoinosi- 
tide-derived second messengers is not a prerequisite for 
mAChR sequestration. Key Words: Human SH-SYdY 
neuroblastoma-Muscarinic cholinergic receptor internal- 
ization-Phosphoinositide hydrolysis-Digitonin permea- 
bilization. 
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Agonist occupancy of neural muscarinic acetylcho- 
line receptors (mAChRs) elicits not only a rapid mod- 
ulation of either adenylyl cyclase or phosphoinositi- 
dase C (PIC) activities, but also a slower adaptive re- 
sponse in which the cell surface receptors are 
internalized into a more hydrophobic cell compart- 
ment. The latter process, termed receptor sequestra- 
tion, can be monitored following cell fractionation as 
a redistribution of cell surface receptors into a mem- 
brane fraction that exhibits a lower density than that 
of the plasma membrane (Harden et al., 1985; Fraey- 
man and Buyse, 1989). However, it is more routinely 
detected as an agonist-induced reduction in the num- 
ber of binding sites for hydrophilic ligands in intact 
cells (Fiegenbaum and El-Fakahany, 1985; Baumgold 
et al., 1989; Cioffi and El-Fakahany, 1989; Thomp- 
son and Fisher, 1990). Two lines of evidence suggest 
that the sequestration of mAChRs is of physiological 
importance. First, once the receptor becomes internal- 
ized, its ability to couple to its intracellular effector 
enzyme, e.g., PIC, may be lost (Thompson and 
Fisher, 199 l), and second, the extent of agonist-in- 
duced mAChR sequestration is predictive of the de- 
gree of subsequent receptor down-regulation (Thomp- 
son and Fisher, 1990). 
Despite frequent documentation of the agonist-in- 
duced sequestration of mAChRs, the molecular mech- 
anism( s) underlying receptor internalization remain 
largely unknown. One factor that may account for 
this paucity of information is the routine use of intact 
cells, for which manipulations of intracellular milieu 
are not readily attained. Although the use of permea- 
bilized cells could potentially circumvent this prob- 
lem, no systematic assessment of this preparation for 
studies of cell surface receptor internalization has yet 
appeared. It is possible that receptor sequestration 
would be compromised when the plasma membrane 
barrier is disrupted. Furthermore, even if receptor se- 
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questration persists in permeabilized cells, it may not 
be readily detectable because the internalized recep- 
tors could be more accessible to hydrophilic radioli- 
gands than in intact cells. The latter factor may ac- 
count for previous unsuccessful attempts to monitor 
the sequestration of P,-adrenergic receptors in per- 
meabilized cell preparations when assessed by means 
of radioligand binding (Fratelli et al., 1989; Lohse et 
al., 1990). In a previous study (Thompson et al., 
1991), preliminary data were obtained to suggest that 
digitonin-permeabilized SK-N-SH cells were capable 
of mAChR sequestration. To explore this possibility 
further, in the present study we have evaluated the 
feasibility of using a permeabilized preparation of hu- 
man SH-SY-5Y neuroblastoma cells for studies of 
mAChR sequestration, as monitored by a loss of cell- 
surface N-methylscopolamine (NMS) binding sites. 
These cells possess a large number of mAChRs, pre- 
dominantly of the m3 subtype, as defined from immu- 
nological, biochemical, and pharmacological criteria, 
that are linked to phosphoinositide hydrolysis and 
Ca2+ signaling (Lambert et al., 1989; Cioffi and 
Fisher, 1990; Lambert and Nahorski, 1990; Wall et 
al., 1991). We report here that an agonist-induced loss 
of [3H]NMS sites is retained in SH-SY-5Y cells even 
after the plasma membrane bamer has been permea- 
bilized by addition of either digitonin, a nonionic de- 
tergent, or two bacterial toxins, namely, streptolysin- 
0 (SLO) and the a-toxin from Staphylococcus uureus. 
The characteristics of receptor sequestration in per- 
meabilized cells resemble those of intact cells in terms 
of kinetics, agonist concentration dependence, and 
muscarinic agonist specificity. mAChR sequestration 
in permeabilized cells is largely independent of intra- 
cellular Ca2+ or ATP, assay components required for 
stimulated phosphoinositide hydrolysis, but can be 
inhibited by guanosine 5'-0-(2-dithiophosphate) 
(GDPPS). For digitonin-permeabilized cells, mAChR 
sites that are internalized following agonist addition 
become increasingly accessible to [3H]NMS when de- 
tergent concentrations are used that are higher than 
those required for permeabilization of the plasma 
membrane alone. The results suggest that, under de- 
fined conditions, a permeabilized cell preparation 
may be used to advantage in studies of mAChR se- 
questration. A preliminary account of part of this 
study has appeared elsewhere (Slowiejko and Fisher, 
1993). 
MATERIALS AND METHODS 
i3H]NMS (79.5 Ci/mmol), [3H]quinuclidinyl benzilate 
([,H]QNB; 45.4 Ci/mmol), and [3H]oxotremorine-M ([3H]- 
0x0-M; 87.5 Ci/mmol) were obtained from New England 
Nuclear (Boston, MA, U.S.A.). [3H]Scopolamine (74.9 Ci/ 
mmol) was custom-synthesized by Amersham Cop.  Areco- 
line, bethanechol, pilocarpine, atropine, cholic acid, 
NADH, and ATP were purchased from Sigma Chemical 
Co. (St. Louis, MO, U.S.A.). Digitonin, a-toxin from S. 
aureus, and thapsigargin were from Calbiochem Corp. (La 
Jolla, CA, U.S.A.). SLO was from Wellcome Diagnostics, 
U.K. 0x0-M was purchased from Research Biochemicals, 
Inc. (Natick, MA, U.S.A.). GDPpS was from Boehringer 
Mannheim (Indianapolis, IN, U.S.A.). Fura-2 acetoxy- 
methyl ester and fura-2 (free acid) were obtained from Mo- 
lecular Probes (Eugene, OR, U.S.A.). Tissue culture sup- 
plies were purchased from Corning Glass Works (Corning, 
NY, U.S.A.). Powdered Dulbecco's modified Eagle's me- 
dium and fetal calf serum were obtained from GIBCO 
(Grand Island, NY, U.S.A.). SH-SY-5Y neuroblastoma 
cells were obtained from Dr. June Biedler (Sloan Kettering 
Institute, New York, NY, U.S.A.). The source of SK-N-SH 
cells was as previously described (Fisher and Snider, 1987). 
Antibodies to the mAChR subtypes were raised against mus- 
carinic i, loop fusion proteins, as previously described (Le- 
vey et al., 1990, 1991). 
Cell culture conditions 
Human SH-SY-5Y or SK-N-SH cells were grown in tis- 
sue culture flasks (75-cm2/250 ml) in 20 ml of Dulbecco's 
modified Eagle's medium supplemented with 10% (vol/vol) 
fetal calf serum (medium I). Cells were grown for 10-20 
days at 37°C in an atmosphere consisting of 10% C02 and 
90% humidified air. Cells were detached by aspirating me- 
dium I and isolating the cells after incubation with a modi- 
fied Pucks D, solution (Fisher and Snider, 1987). 
Immunoprecipitation of mAChR subtypes 
The procedure of Levey et al. (1990, 1991) was adopted, 
with minor modifications. A crude membrane preparation 
was obtained by Dounce homogenization of SH-SY-5Y or 
SK-N-SH cells (2 mg of protein/ml) in 10 mM Tris and 1 
mM EDTA buffer (pH 7.5) that contained protease inhibi- 
tors (100 pg/ml of phenylmethylsulfonyl fluoride, 1.5 pg/ml 
of leupeptin, and I .5 pg/ml of aprotinin) followed by centrif- 
ugation at 20,000 g for 10 min at 4°C. To solubilize 
mAChRs, membranes were first resuspended in Tris-EDTA 
buffer containing 0.4% digitonin (Wako BioProducts, Rich- 
mond, VA, U.S.A.) and 0.04% cholic acid at a concentra- 
tion of 1 mg of protein/ml of buffer and then homogenized 
and left on ice for 1 h. Membranes were then pelleted 
(12,000 g for 30 min), and the supernatants were retained 
on ice in the presence of 6 nM [3H]NMS for 30 min. [3H]- 
NMS-labeled receptors were then incubated with antisera 
(diluted 1:40) for 4 h at 4°C in microcentrifuge tubes. Goat 
anti-rabbit IgG (Pel-Freez) was then added to a final dilu- 
tion of 1% After overnight incubation at 4"C, samples were 
centrifuged at 2,000 g for 10 min. Immunoprecipitates were 
then washed twice with Tris-EDTA buffer containing 0.1 % 
digitonin and 0.01% cholic acid and resuspended in 1% so- 
dium dodecyl sulfate, and radioactivity was determined 
after addition of 5 ml of Universol scintillation fluid. Con- 
trols that used nonimmune rabbit antisera to determine 
nonspecific trapping of receptor in immunoprecipitates 
(< 10% of total radioactivity) were subtracted from experi- 
mental values. Approximately 100% of radioactivity asso- 
ciated with solubilized receptors was recovered in the im- 
munoprecipitates. However, the efficiency of mAChR solu- 
bilization ranged from 20 to 40%, a value comparable to 
that previously obtained (Levey et al., 1991; Wall et al., 
1991). 
Radioligand binding 
The binding of [3H]NMS to mAChRs on intact SH-SY- 
5Y cells was as previously described (Fisher, 1988). In brief, 
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cells were incubated with [3H]NMS in buffer A (142 mM 
NaCI, 5.6 m M  KCI, 2.2 mM CaCI,, 3.6 mM NaHCO,, 1 
mM MgCI,, 5.6 mM D-glucose, and 30 mM HEPES, pH 
7.4) for 18 h at 4°C. Permeabilized cells were incubated in 
KGEH buffer ( 1  39 m M  potassium glutamate, 2 mM ATP, 
4 mM MgCI,, 10 mM LiCI, 10 mMEGTA, 2.2 mMCaCI, 
(free [Ca"] - 60nM) and 30 mM HEPES, pH 7.4) with 
either [3H]NMS (or [3H]scopolamine) for 18 h at 4°C or 
[3H]QNB for 60 min at 37°C. For both intact and permea- 
bilized cells, reactions were rapidly terminated by filtration 
through Whatman GF/B glass fiber filters, and radioactivity 
was determined after addition of 5 ml of Universol scintilla- 
tion fluid. As previously noted for SK-N-SH cells (Fisher, 
1988), a day-to-day variation in mAChR densities in SH- 
SY-5Y cells was observed (see Table 1). 
Cell permeabilization 
Unless indicated otherwise, cells were permeabilized with 
20 phfdigitonin in KGEH buffer (-Ca2+) for 5 rnin at 37°C 
at a protein concentration of -2-3 mg/ml. This ratio of 
digitonin:cell protein was maintained throughout the study. 
Failure to exclude trypan blue dye (0.05% wt/vol) was used 
to assess permeabilization. Alternatively, cells (2-3 mg of 
protein/ml) were permeabilized by addition of 0.5 IU/ml of 
SLO for 10 min or 200 U/ml of a-toxin from S. aureu~ for 
30 min. Permeabilized cells were then centrifuged, washed 
with an equal volume of KGEH buffer (minus permeabiliz- 
ing agent), and resuspended in the same buffer with and 
without agonist. Incubations (free [Ca2*] - 60 nM unless 
otherwise indicated) were then allowed to proceed at 37°C 
for the time(s) indicated. Reactions were terminated by ad- 
dition of 4 volumes of ice-cold KGEH buffer followed by 
centrifugation at 300 g for 3.5 rnin at 4°C. Cells were then 
resuspended in KGEH buffer and assayed for radioligand 
binding as described. Although the 4°C temperature was 
routinely used for determination of [3H]NMS binding, simi- 
lar results were obtained when the cells were incubated at 
15°C for 4 h. Protein content was measured by the method 
of Geiger and Bessman ( 1972). 
Measurement of cytoplasmic Ca2+ concentration 
(ICa2+l*) 
[CaZ+], values in SH-SY-5Y cells were determined by 
monitoring fura-2 fluorescence in a Shimadzu model RF- 
5000 spectrofluorophotometer using the dual wavelength 
method as previously described (Thompson et al., 1991). 
Concentrations of free Ca2+ in Ca2+/EGTA buffers were 
measured directly after addition of fura-2 (free acid). 
Lactate dehydrogenase (LDH) 
ski and LaDue (1955). 
Data analysis 
Data are mean k SEM (or range where n = 2) values for 
the number of separate experiments performed. Student's 
two-tailed t tests were used to evaluate the statistical differ- 
ences of the means of paired or unpaired sets of data. 
LDH was quantified essentially as described by Wroblew- 
RESULTS 
Expression of m1-m5 muscarinic receptor subtypes in 
SK-N-SH and SH-SY-5Y cells 
Previous studies of mAChR sequestration in this 




FIG. 1. lmmunoprecipitation of mAChR subtypes present in SK- 
N-SH and SH-SY-5Y cells. mAChRs present in crude membrane 
preparations were first solubilized by addition of 0.4% digitonin 
and 0.04% cholic acid and then labeled by addition of 6 nM [%I]- 
NMS. Labeled receptors were then incubated with antisera to 
each of the mAChR subtypes, and radioactivity recovered in the 
immunoprecipitates was determined. Results are expressed as 
radioactivity recovered in each immunoprecipitate as a function of 
the total recovered. Data are mean & SEM (bars) values for the 
number of separate experiments indicated in parentheses. 
toma, a cell line that possesses mAChRs of the M3 
subtype, as determined from biochemical and phar- 
macological criteria (Fisher and Heacock, 1988). Be- 
cause of the possibility that the characteristics of 
mAChR sequestration might differ for individual re- 
ceptor subtypes, in preliminary experiments we deter- 
mined the proportion of mAChR subtypes present on 
both SK-N-SH neuroblastoma and its stable neuro- 
blast subclone, SH-SY-SY, by means of m,-m5 sub- 
type-selective antisera (Fig. 1 ). Immunoprecipitation 
of solubilized mAChR proteins confirmed that the m3 
mAChR is the major subtype present on both SK-N- 
SH and SH-SY-5Y cells. However, SH-SY-5Y cells 
consistently (over an 1 8-month period) exhibited a 
greater proportion of m3 receptors than the parent 
SK-N-SH cell line (81 +- 2 vs. 57 f 4%; p < 0.001). 
Although a previous study pointed to the predomi- 
nance of the m, mAChR in these cells (Serra et al. 
1988), < 10% of immunoreactivity was associated 
with m,, m,, m4, or m, subtypes in SH-SY-5Y cells 
(Fig. 1). Thus, SH-SY-SY cells, which express a rela- 
tively homogeneous population of m3 mAChRs, were 
used for all subsequent experiments. 
Ligand binding characteristics of mAChRs on intact 
and permeabilized SH-SY-5Y cells 
Scatchard analysis of [3H]NMS binding to intact 
SH-SY-5Y cells revealed a mean B,,, value of 366 
fmol/mg of protein and a KD value of 1.5 nM (Table 
1). When SH-SY-5Y cells were incubated with 20 pM 
digitonin for 5 min at 37"C, 84 f 1% (n = 40) of cells 
were permeabilized, as assessed by failure to exclude 
trypan blue (mol wt = 960). Under these conditions, 
49 -+ 6% (n = 3) ofcellular lactate dehydrogenase activ- 
ity was released. When compared with intact cells, 
permeabilized cells exhibited an increased B,, value 
for [3H]NMS (528 fmol/mg of protein) and a reduced 
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TABLE 1. Ligand binding characteristics of intact and 
digitonin-permeabilized SH-SY-5 Y cells 
Intact Permeabilized 
B,, (fmol/mg of protein) 366 f 75 (4) 528 f 94 (7) 
Range 189-5 18 339-986 
Range 0.84-2.56 0.14-1.74 
KD (nM) 1.5 & 0.4 (6) 0.5 f 0.2 (7)" 
mAChR number/cell 21 -+ 2 x 103 (7) 24 1 x 103 (7) 
Range 16 - 28 X 10' 19 - 29 X lo3 
~ ~ ~ ~~ ~~ ~ 
The binding of [3H]NMS to intact or digitonin-permeabilized 
cells was analyzed by Scatchard analysis. The mAChR number per 
cell was assessed at 6 nM ['HINMS, a concentration at which 80- 
92% of mAChR sites are occupied. Data are mean & SEM values for 
the number of experiments shown in parentheses. The range of 
values obtained is also shown. 
a p < 0.05. 
K,, (0.5 nM). However, only the change in KD value 
was statistically significant (Table 1). Because the 
trend toward an increased B,, value for [3H]NMS 
binding could conceivably be attributed to a loss of 
cytosolic protein from permeabilized cells (20-45% of 
total), we also calculated mAChR densities in the two 
preparations in terms of receptor number per cell. 
Both intact and permeabilized SH-SY-5Y cells ex- 
pressed -2 1,000-24,000 receptors per cell (Table 1). 
Thus, whereas digitonin permeabilization results in a 
small increase in the affinity of mAChRs for [3H]- 
NMS, it has no effect on receptor density. 
Characteristics of agonist-induced loss of 13H]NMS 
sites in digitonin-perrneabilized cells 
When digitonin-permeabilized cells were incubated 
in the presence of 1 mA4 0x0-M, a time-dependent 
(11,2 - 5 min) loss of cell surface [3H]NMS binding 
sites was observed, which, after 30 min of agonist ex- 
posure, amounted to -25-30% of those sites origi- 
nally present. In contrast, addition of 0x0-M had lit- 
tle or no effect on total mAChR number as monitored 
by the binding of [3H]QNB, a lipophilic antagonist 
(Fig. 2). However, a small reduction in the binding of 
[3H]scopolamine, another lipophilic antagonist, was 
observed after 30 min of 0x0-M addition (14 f 5%, n 
= 4). The nonequivalence of [3H]scopolamine and 
[3H]QNB binding data may reflect the greater degree 
of lipophilicity of QNB (Frey, 1984). Thus, [3H]QNB 
appears to recognize a greater fraction of available 
mAChRs than does [3H]scopolamine, and, conse- 
quently, the use of [3H]scopolamine overestimates to- 
tal mAChR loss. Scatchard analysis of [3H]NMS bind- 
ing to control and 0x0-M-treated cells demonstrated 
that the loss of binding sites was due to a reduction in 
the number of receptor sites without a change in li- 
gand affinity (Fig. 3). The loss of cell surface [3H]- 
NMS binding sites was concentration dependent 
(EC,, for 0x0-M - 10 pM; data not shown) and ago- 
nist specific (Fig. 4). Thus, as previously noted for 
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FIG. 2. 0x0-M addition results in a time-dependent loss of [3H]- 
NMS sites from digitonin-permeabilized SH-SY-5Y neuroblas- 
toma. Cells were first permeabilized for 5 rnin in the presence of 
20 juW digitonin, washed free of detergent, and incubated for the 
times indicated in KGEH buffer in the presence or absence of 1 
mM 0x0-M. Cells were then washed free of agonist at 4"C, and 
aliquots were taken for either rH]NMS or f'H]QNB radioligand 
binding. Results are expressed as specific binding relative to con- 
trols that were incubated with KGEH alone. Data (for n > 3) are 
mean & SEM (bars) (or range where n = 2) values for the number 
of separate experiments indicated in parentheses. The binding of 
[3H]NMS to control cells was unchanged over a 60-min incubation 
period. 
addition of bethanechol, pilocarpine, and arecoline, 
partial agonists for stimulated phosphoinositide turn- 
over, elicits little or no mAChR sequestration in per- 
meabilized SH-SY-5Y cells. 
mAChR sequestration and phosphoinositide 
hydrolysis 
In a previous study with intact SK-N-SH cells, 
mAChR sequestration was unaffected by chelation of 
extracellular Ca2+, a condition that resulted in a par- 
tial inhibition of stimulated phosphoinositide hydroly- 
200 400 600 800 
(fmollrng protein) 
Bound 
FIG. 3. Scatchard analysis of [3H]NMS binding to digitonin-per- 
meabilized cells that had been incubated in either the absence 
[control (Con; O)] or presence (0) of 1 mM 0x0-M for 30 min. 
Cells were washed to remove the agonist, and aliquots were 
taken for radioligand binding at 4°C for 18 h. Data shown are 
from one of five experiments. The mean & SEM values for the 
B,,, from the five experiments were 473 & 73 and 362 & 45 
fmol/mg of protein for control and 0x0-M-treated cells, respec- 
tively (p < 0.05, matched-pair). The corresponding K, values 
were 0.23 ? 0.05 and 0.21 f 0.06 nM. 
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FIG. 4. Muscarinic agonists differ in their ability to induce the loss 
of [3H]NMS sites from digitonin-permeabilized SH-SY-5Y neuro- 
blastoma cells. Permeabilized cells were incubated with 1 mM 
0x0-M, 1 mM pilocarpine, 1 mM arecoline, or 10 mM bethanechol 
for 30 min at 37°C. Cells were washed at 4OC to remove agonist, 
and then aliquots were taken for either [3H]NMS or PH]QNB bind- 
ing. Results are expressed as specific binding relative to controls 
that were incubated in the absence of agonist. Data are mean 
t SEM (bars) values for the number of separate experiments indi- 
cated in parentheses. 
sis (Thompson et al., 1991). The ability to monitor 
mAChR sequestration in a permeabilized cell prepara- 
tion has permitted a more precise definition of the 
relationship, if any, between receptor internalization 
and the production of phosphoinositide-derived sec- 
ond messengers (Fig. 5). When ATP was omitted 
[conditions under which mAChR-stimulated inositol 
phosphate production is inhibited by 70-90% (see 
Fisher et al., 1990)], the extent of mAChR internaliza- 
tion remained unchanged. Furthermore, the magni- 
tude of mAChR sequestration was little changed 
when the ATP concentration was increased from 2 to 
4 mM. Inclusion of 50 pM guanosine 5‘-0-(3-thiotri- 
m I I 
ATqrnM) - 4 2 2 2 2 2 
GTPIIWM) - - 50 - - - - 
GDP8WmM) - - - 2 5 - -  
Ca**(nM) 60 60 60 60 60 ‘10 503 
FIG. 5. Regulation of mAChR sequestration by ATP, guanine nu- 
cleotides, and Ca2+. Digitonin-permeabilized cells were incubated 
in the absence or presence of 1 mM 0x0-M for 30 rnin with ATP, 
GTPyS, GDPPS, or Ca2+ at the concentrations indicated. Results 
are expressed as percent loss of [3H]NMS sites, relative to that 
observed under standard assay conditions (KGEH buffer that 
contained 2 mM ATP and 60 nM Ca2+; see Materials and Meth- 
ods). Under standard assay conditions 20-25% of r3H]NMS sites 
were lost in the presence of 0x0-M. Data are mean f SEM (bars) 
(or range, where n = 2) values for the number of separate experi- 
ments indicated in parentheses. *Different from 100%. p i 0.05. 
0x0-M 
2.5 R 
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b 260 
Time (sec) 
FIG. 6. An agonist-induced rise in [Ca2+], is not required for 
rnAChR sequestration. Intact cells were first loaded with fura-2 
and then incubated in a modified buffer A (-Ca2+, 0.2 mM EGTA). 
After 60 s, either modified buffer A (A) or 1 pA4 thapsigargin (6) 
was added, and cells were allowed to preincubate for 10 rnin at 
37°C before addition of 1 mM 0x0-M. In A, addition of 0x0-M 
resulted in a rise in [Ca”], from 4 0  to 281 nM. In 6, little or no 
increase in [Ca”], occurred in the presence of the agonist. Thap- 
sigargin increased [Ca2+], from 4 0  to 42 nM. Results shown are 
from one of three experiments that gave similar results. The abil- 
ity of 0x0-M to induce a loss of [3H]NMS sites under conditions A 
and B is given. 
phosphate) (GTPyS), which results in the activation 
of PIC (Fisher et al., 1989; Cioffi and Fisher, 1990), 
had no effect on receptor internalization when added 
alone. In addition, it failed to enhance the extent of 
agonist-induced mAChR sequestration. In contrast, 
inclusion of 2 or 5 mM GDPpS resulted in a 48-53% 
inhibition of mAChR sequestration, values compara- 
ble to those obtained for inhibition of stimulated 
phosphoinositide hydrolysis in permeabilized SK-N- 
SH or SH-SY-SY cells (Cioffi and Fisher, 1990; 
Thompson et al., 1991). Because the activation of 
mAChRs in SH-SY-5Y cells results in a rapid tran- 
sient rise in [Ca2+],, which itself may serve further to 
activate PIC, we also determined the effect of [Ca2+], 
on mAChR sequestration. The extent of Oxo-M-in- 
duced sequestration was unaltered when [Ca2+Ii was 
buffered at concentrations that either do not support 
PIC activity [ t 1 0  &(Fisher et al., 1989)] or approxi- 
mate the peak [Ca2+], achieved during the first 5-10 s 
of agonist addition (-500 nM). Further evidence 
that changes in [Ca2’], do not modulate the extent of 
sequestration was obtained from parallel experiments 
in which intact cells were preincubated with thapsi- 
gargin, an inhibitor of the microsomal Ca*+-ATPase 
pump. Whereas pretreatment of SH-SY-5Y cells with 
1 pM thapsigargin abolished the ability of 0x0-M to 
induce a rise in [Ca2+],, it had little effect on the extent 
of mAChR sequestration (Fig. 6) .  
Comparison of the extent of mAChR sequestration in 
intact and permeabilized cells 
The magnitude of the 0x0-M-induced loss of [3H]- 
NMS sites observed for intact cells (-40%) was con- 
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Percent of ['HINMS 
sites lost In presence 
of 0x0-M 
FIG. 7. Fewer [3H]NMS sites are lost from cells that are permea- 
bilized before agonist addition than from cells that are first ex- 
posed to agonist and then permeabilized. Three separate proto- 
cols were used. A Intact cells were first incubated in the pres- 
ence or absence of 1 mM 0x0-M for 30 min. Cells were then 
washed free of agonist, and aliquots were then taken for [3H]- 
NMS binding. B: Cells were first permeabilized in the presence of 
either 20 pM digitonin (Dig.) or 0.5 lU/ml of SLO (as indicated by 
the breached plasma membrane), the cells were washed to re- 
move these agents, and then the permeabilized cells were incu- 
bated in the absence or presence of 1 mM 0x0-M for 30 min. 
After removal of the agonist by washing, aliquots of the cells were 
taken for [3H]NMS binding. C: Intact cells were first incubated 
with or without 1 mM 0x0-M for 30 min and then permeabilized 
with digitonin or SLO (in the continuing presence of the agonist). 
Cells were then washed with KGEH buffer, and aliquots were 
taken for [3H]NMS binding. For all three protocols, results are 
expressed as percentages of t3H]NMS sites lost in the presence 
of agonist, relative to the controls. Data are mean c SEM (bars) 
values for the number of separate experiments shown in paren- 
theses. "Different from protocols A or C, p < 0.05. 
sistently found to be greater than that obtained for 
digitonin-permeabilized cells (-25%; Fig. 7A and B). 
To determine whether this differential loss of [3H]- 
NMS sites was specific to the digitonin treatment, 
cells were also rendered permeable by addition of 
SLO (Ahnert-Hilger et al., 1989). Under these condi- 
tions, 85% of the cells failed to exclude trypan blue, 
and 2 1 & 5% (n = 3 )  of the cellular LDH was released. 
When 1 mM 0x0-M was added to SLO-permeabi- 
lized cells, the loss of t3H]NMS sites (- 25%) was com- 
parable to that obtained for digitonin-treated cells 
(Fig. 7B). However, if intact cells were first incubated 
with 0x0-M and then permeabilized with either digito- 
nin or SLO, the loss of [3H]NMS binding sites was 
comparable to that observed for cells incubated with 
0x0-M alone (Fig. 7C). Both digitonin and SLO re- 
sult in the formation of pores in the plasma mem- 
brane that allow the passage of large-molecular- 
weight compounds such as LDH (135,000). In con- 
trast, the a-toxin from S. aweus is reported to result 
in the formation of pores 1-2 nm in diameter, which 
allows the entry of trypan blue but not the release of 
LDH (Ahnert-Hilger et al., 1989). Of the cells per- 
meabilized with the a-toxin, 80435% failed to exclude 
trypan blue. When these cells were then incubated 
with 1 mMOxo-M for 30 min, 28 f 5% (n = 4) of 
[3H]NMS sites were lost, a value similar to that ob- 
tained for either digitonin- or SLO-treated cells. This 
loss of [3H]NMS sites in a-toxin-permeabilized cells 
was less marked than for intact cells, monitored con- 
currently (42 f 3% of total, n = 4; p < 0.05). In con- 
trast to digitonin or SLO permeabilization, addition 
of the a-toxin induced release of little or no cellular 
LDH activity (4 f 0%, n = 3) ,  a value indistinguish- 
able from LDH release from nominally intact cells (2 
+_ 0% of total, n = 3) .  
Sequestered mAChR sites become accessible to PHI- 
NMS at higher concentrations of digitonin 
Relatively low concentrations of digitonin (20 p M )  
were required for permeabilization of the majority of 
SH-SY-5Y cells. However, when higher concentra- 
tions of the nonionic detergent were used, an in- 
creased accessibility of the sequestered mAChRs to 
[3H]NMS was observed. Thus, when intact cells were 
first challenged with 1 mM 0x0-M and then perme- 
abilized by addition of 20 pM digitonin, 35-40% of 
[ 'HINMS sites originally present were inaccessible. 
However, when the concentration of digitonin was 
increased to 80 pM, only 7% of the sites were lost (Fig. 
8). If cells were initially permeabilized with this higher 
concentration of digitonin before 0x0-M addition, 
little or no loss of [3H]NMS sites could be observed 
(data not shown). [3H]NMS binding to control cells 
was unaffected by digitonin in the 10-80 pM concen- 
tration range, as was [3H]QNB binding to either con- 
trol or agonist-treated cells (Fig. 8). Higher concentra- 
tions of digitonin (1 60 p M )  resulted in a substantial 
loss of [3H]NMS and [3H]QNB sites from both con- 
trol and 0x0-M-treated cells. 
DISCUSSION 
In the present study, we have extensively character- 
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FIG. 8. mAChR sites in digitonin-permeabilized cells that are inac- 
cessible to t3H]NMS can be exposed by use of higher concentra- 
tions of the detergent. Intact cells were first incubated in the pres- 
ence (solid symbols) or absence (open symbols) of 1 mM 0x0-M 
for 30 min and then permeabilized for 5 min with digitonin at the 
concentrations indicated. Cells were then washed free of deter- 
gent and agonist, and aliquots were taken for either [3H]NMS or 
[3H]QNB binding. Data are mean c SEM (bars) values for tripli- 
cate replicates from one of three experiments that gave similar 
results. Insets: Percentage of mAChR sites that are inaccessible 
to [3H]NMS, as a function of digitonin concentration. Data are 
mean & SEM (bars) values for three separate experiments. 
J. Neurochem., Vol. 62, No. 5, 1994 
mAChR SEQUESTRATION IN PERMEABILIZED CELLS 1801 
agonist addition and demonstrate that permeabilized 
preparations of SH-SY-SY neuroblastoma cells can 
be readily used for studies of mAChR sequestration. 
Cells rendered permeable with digitonin, as moni- 
tored by trypan blue exclusion and LDH release, pos- 
sessed a full complement of mAChRs and exhibited 
characteristics of mAChR sequestration similar to 
those previously observed for intact cells. Thus, addi- 
tion of 0x0-M to permeabilized SH-SY-SY cells re- 
sulted in a selective loss of cell surface mAChR sites, 
i.e., without a loss of total receptor number, as moni- 
tored by [3H]QNB, which was concentration depen- 
dent and occurred within a time frame of minutes (t,,2 - 5 min). Although previous studies with electropor- 
ated SH-SY-SY cells indicated that the permeabiliza- 
tion process can result in an altered agonist efficacy 
profile for activation of PIC (Wojcikewicz et al., 
19904, the inability of partial muscarinic agonists 
(bethanechol, arecoline, or pilocarpine) to induce a 
significant amount of receptor sequestration in digito- 
nin-permeabilized SH-SY -5Y cells is in agreement 
with results previously obtained with intact cells 
(Thompson and Fisher, 1990). The ability of 0x0-M 
to elicit a loss of cell surface mAChRs was not re- 
stricted to cells permeabilized with the nonionic de- 
tergent digitonin but was also observed for cells per- 
meabilized with two bacterial exotoxins, SLO and the 
a-toxin from S. aureus (Ahnert-Hilger et al., 1989). 
Taken collectively, the present results indicate that 
m AChR sequestration can be initiated even when the 
structural integrity of the plasma membrane has been 
compromised by permeabilization. Furthermore, the 
data obtained with permeabilized cells suggest that 
when internalized, mAChRs exist in a cellular com- 
partment that remains relatively inaccessible to [3H]- 
NMS even after the plasma membrane bamer has 
been removed. This may reflect the presence of the 
mAChR in an endocytotic vesicle, as has been de- 
scribed for the P,-adrenergic receptor (Hertel et al., 
1983; von Zastrow and Kobilka, 1992). 
Of the three agents used for cell permeabilization, 
the steroid glycoside digitonin, which targets the 
plasma membrane owing to its relatively high concen- 
tration of cholesterol, has had the most widespread 
use. However, concentrations of digitonin that selec- 
tively permeabilize the plasma membrane, while 
sparing intracellular membranes, must be used (Sara- 
fian et al., 1987). The majority (85%) of SH-SY-SY 
cells were permeabilized following short-term incuba- 
tion with 20 pMdigitonin, and mAChR sequestration 
was consistently detected in cells thus treated. How- 
ever, when higher concentrations of digitonin were 
used, sequestered mAChRs then became accessible to 
[3H]NMS (Fig. 8). Thus, the concentration of digito- 
nin used appears critical to the successful application 
of permeabilized cells to studies of mAChR sequestra- 
tion in SH-SY-SY neuroblastoma. 
mAChR sequestration observed for SH-SY-SY 
cells permeabilized before agonist addition, while reli- 
ably and reproducibly observed, was consistently 30- 
35% less than that monitored either for intact cells or 
for cells permeabilized after agonist addition (see Fig. 
7). This attenuation in responsiveness could conceiv- 
ably reflect a loss of cytosolic components that oc- 
curred during the permeabilization process. However, 
because the 0x0-M-mediated loss of [3H]NMS sites 
observed following permeabilization with a-toxin 
(which releases no LDH) is comparable to that ob- 
tained following digitonin treatment (which releases 
50% of the cellular LDH), it appears unlikely that the 
leakage of a high-molecular-weight component is a 
relevant factor. A role for a low-molecular-weight 
component remains possible, although ATP, Ca2+, or 
guanine nucleotides do not appear to be likely candi- 
dates. Two other possible explanations need to be con- 
sidered: first, that the permeabilization process itself 
partially impairs the mAChR sequestration machin- 
ery, and second, that [3H]NMS may have greater ac- 
cess to mAChRs present in endocytotic vesicles de- 
rived from permeabilized cells than from intact cells. 
Although agonist occupancy of mAChRs on SH- 
SY-SY cells leads to both the activation of PIC and 
receptor sequestration, the production of phosphoino- 
sitide-derived second messengers appears not to be 
required for receptor internalization, a finding consis- 
tent with previous observations obtained for m, 
mAChRs transfected into U293 cells (Lameh et al., 
1992). Thus, in the present study, neither the exclu- 
sion of ATP nor the lowering of [Ca2+], to t10 nM, 
both ofwhich strongly inhibit receptor-stimulated ino- 
sitol lipid hydrolysis (Fisher et al., 1989, 1990), had 
any effect on mAChR sequestration. Depletion of the 
inositol trisphosphate-sensitive Ca2+ pools with thap- 
sigargin also failed to block receptor internalization. 
In contrast, inclusion of GDPDS inhibited mAChR 
sequestration and phosphoinositide hydrolysis (see 
Cioffi and Fisher, 1990) to the same extent. This is 
consistent with previous speculation that an event be- 
fore PIC activation, possibly at the level of a guanine 
nucleotide binding protein, is linked to mAChR inter- 
nalization (Thompson et al., 199 1). Thus, receptor 
activation, but not second messenger production, ap- 
pears to be a prerequisite for mAChR sequestration. 
Permeabilized SK-N-SH and SH-SY-SY neuroblas- 
toma cells have previously been used for studies of 
mAChR coupling to PIC (Fisher et al., 1989; Cioffi 
and Fisher, 1990; Wojcikiewicz et al., 1990a), 
mAChR-stimulated Ca2+ release (Wojcikiewicz et al., 
1990b), and metabolism of inositol phosphate 
isomers generated on receptor activation (Fisher et 
al., 1990). To this list can now be added mAChR se- 
questration, a slower adaptive response that results 
from continuous agonist occupancy of the mAChR 
(for kinetic comparisons, see Fisher et al., 1994). It is 
also pertinent to note that the SH-SY-SY cell line pos- 
sesses an abundance of a relatively homogeneous pop- 
ulation of m3 receptors. Because it is increasingly evi- 
dent that receptor subtypes, e.g., P I ,  &, and P3-adren- 
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ergic (see Suzuki et al., 1992; Nantel et al., 1993) differ 
considerably in their propensity to undergo sequestra- 
tion, the issue of receptor heterogeneity assumes ma- 
jor importance. Although transfected cells can pro- 
vide an alternative approach for studying the internal- 
ization of a single receptor subtype, the results 
obtained may be influenced by the host cell type. 
In summary, the present results indicate that 
mAChR sequestration can be successfully monitored 
in permeabilized neuroblastoma cells. This prepara- 
tion may facilitate future studies of the interrelation- 
ships among receptor occupancy, activation of phos- 
phoinositide hydrolysis, and receptor internalization. 
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